Utilization Of Magnetic-Activated Cell Sorting And High-Density Single Nucleotide Polymorphism Microarrays Improves Diagnostic Yield And Prognostic Value In Clinical Testing For Patients With Multiple Myeloma And Normal Routine Chromosome Study